Health Care & Life Sciences » Pharmaceuticals | Heilongjiang ZBD Pharmaceutical Co. Ltd.

Heilongjiang ZBD Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,398
1,570
2,043
2,350
3,085
2,715
Cost of Goods Sold (COGS) incl. D&A
511
636
518
923
1,441
884
Gross Income
887
934
1,525
1,427
1,644
1,831
SG&A Expense
295
353
770
928
1,013
1,260
EBIT
540
555
708
561
623
508
Unusual Expense
-
-
-
-
-
16
Non Operating Income/Expense
4
13
11
62
55
23
Interest Expense
47
60
51
53
52
64
Pretax Income
504
550
694
587
650
551
Income Tax
76
86
114
91
126
87
Equity in Affiliates
3
-
-
-
-
-
Consolidated Net Income
425
464
580
497
523
463
Net Income
437
477
585
510
521
462
Net Income After Extraordinaries
437
477
585
510
521
462
Net Income Available to Common
437
477
585
510
521
462
EPS (Basic)
0.61
0.67
0.69
0.60
0.61
0.54
Basic Shares Outstanding
849
849
849
849
849
849
EPS (Diluted)
0.51
0.56
0.69
0.60
0.61
0.54
Diluted Shares Outstanding
849
849
849
849
849
849
EBITDA
617
657
832
716
759
647
Other Operating Expense
52
26
47
62
8
63
Non-Operating Interest Income
1
4
11
17
16
22
Minority Interest Expense
12
13
6
13
2
1

About Heilongjiang ZBD Pharmaceutical Co.

View Profile
Address
8 Yantai 1st Road
Harbin Heilongjiang 150060
China
Employees -
Website http://www.zbdzy.com
Updated 07/08/2019
HeiLongJiang ZBD Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine. It also engages in the trading of drug and Chinese herbal medicine. Its business areas include Industrial and Commercial.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.